The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins

Journal of Biological Chemistry

Volumn 289, Issue 13, 2014, Pages 8947-8959

  Wei, Saisai ^a   Wang, Hongbo ^a,c   Lu, Chunwan ^b   Malmut, Sarah ^a   Zhang, Jianqiao ^c   Ren, Shumei ^a   Yu, Guohua ^d   Wang, Wei ^d   Tang, Dale D ^a   Yan, Chunhong ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c YANTAI UNIVERSITY   (China)

^d QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; PATHOLOGY; PLATINUM COMPOUNDS;

ACTIVATING TRANSCRIPTION FACTOR; DOWN-REGULATION; DRUG RESISTANCE; GAIN-OF FUNCTION; LYMPH NODE METASTASIS; ONCOGENIC ACTIVITIES; TRANSCRIPTIONAL REGULATOR; TUMOR SUPPRESSION;

TRANSCRIPTION FACTORS;

ACTIVATING TRANSCRIPTION FACTOR 3; CISPLATIN; ETOPOSIDE; MUTANT PROTEIN; PROTEIN P53; PROTEIN P63; ATF3 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB2 PROTEIN, HUMAN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BINDING SITE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME REPRESSION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LYMPH NODE METASTASIS; METASTASIS; NFKB2 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TARGETING; SENSITIZATION; SHARP1 GENE; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; CARCINOGENESIS; CELL MOTION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MUTATION; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ACTIVATING TRANSCRIPTION FACTOR 3; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MUTANT PROTEINS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B P52 SUBUNIT; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84897377102     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.503755     Document Type: Article

References (47)

1. Brosh, R and Rotter, V. (2009) When mutants gain new powers. News from the mutant p53 field. Nat. Rev. Cancer 9, 701-713
2. Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., and Jacks T. (2004) Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847-860 (Pubitemid 40017690)
3. Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., El-Naggar, A. K., and Lozano, G. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119, 861-872 (Pubitemid 40017691)
4. Muller, P. A., and Vousden, K. H. (2013) p53 mutations in cancer. Nat. Cell Biol. 15, 2-8
5. Freed-Pastor, W. A., and Prives, C. (2012) Mutant p53. One name, many proteins. Genes Dev. 26, 1268-1286
6. Neilsen, P. M., Noll, J. E., Suetani, R. J., Schulz, R. B., Al-Ejeh, F., Evdokiou, A., Lane, D. P., and Callen, D. F. (2011) Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget 2, 1203-1217
7. Girardini, J. E., Napoli, M., Piazza, S., Rustighi, A., Marotta, C., Radaelli, E., Capaci, V., Jordan, L., Quinlan, P., Thompson, A., Mano, M., Rosato, A., Crook, T., Scanziani, E., Means, A. R., Lozano, G., Schneider, C., and Del Sal, G. (2011) A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 20, 79-91
8. Montagner, M., Enzo, E., Forcato, M., Zanconato, F., Parenti, A., Rampazzo, E., Basso, G., Leo, G., Rosato, A., Bicciato, S., Cordenonsi, M., and Piccolo, S. (2012) SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature 487, 380-384
9. Muller, P. A., Caswell, P. T., Doyle, B., Iwanicki, M. P., Tan, E. H., Karim, S., Lukashchuk, N., Gillespie, D. A., Ludwig, R. L., Gosselin, P., Cromer, A., Brugge, J. S., Sansom, O. J., Norman, J. C., and Vousden, K. H. (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell 139, 1327-1341
10. Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T., and Prives, C. (2001) A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol. Cell. Biol. 21, 1874-1887 (Pubitemid 32156407)
11. Buganim, Y., Kalo, E., Brosh, R., Besserglick, H., Nachmany, I., Rais, Y., Stambolsky, P., Tang, X., Milyavsky, M., Shats, I., Kalis, M., Goldfinger, N., and Rotter, V. (2006) Mutant p53 protects cells from 12-O- tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction. Cancer Res. 66, 10750-10759 (Pubitemid 44876970)
12. Yan, C., and Boyd, D. D. (2006) ATF3 regulates the stability of p53. A link to cancer. Cell Cycle 5, 926-929
13. Wu, X., Nguyen, B. C., Dziunycz, P., Chang, S., Brooks, Y., Lefort, K., Hofbauer, G. F., and Dotto, G. P. (2010) Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465, 368-372
14. Yin, X., Wolford, C. C., Chang, Y. S., McConoughey, S. J., Ramsey, S. A., Aderem, A., and Hai, T. (2010) ATF3, an adaptive-response gene, enhances TGFβ signaling and cancer-initiating cell features in breast cancer cells. J. Cell Sci. 123, 3558-3565
15. Liu, W., Iiizumi-Gairani, M., Okuda, H., Kobayashi, A., Watabe, M., Pai, S. K., Pandey, P. R., Xing, F., Fukuda, K., Modur, V., Hirota, S., Suzuki, K., Chiba, T., Endo, M., Sugai, T., and Watabe, K. (2011) KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFκB complex in human prostate cancer. J. Biol. Chem. 286, 18949-18959
16. Gargiulo, G., Cesaroni, M., Serresi, M., de Vries, N., Hulsman, D., Bruggeman, S. W., Lancini, C., and van Lohuizen, M. (2013) In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis. Cancer Cell 23, 660-676
17. Huang, X., Li, X., and Guo, B. (2008) KLF6 induced apoptosis in prostate cancer cells through upregulation of ATF3. J. Biol. Chem. 283, 29795-29801
18. Yuan, X., Yu, L., Li, J., Xie, G., Rong, T., Zhang, L., Chen, J., Meng, Q., Irving, A. T., Wang, D., Williams, E. D., Liu, J. P., Sadler, A. J., Williams, B. R., Shen, L., and Xu, D. (2013) ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton. Cancer Res. 73, 3625-3637
19. Hackl, C., Lang, S. A., Moser, C., Mori, A., Fichtner-Feigl, S., Hellerbrand, C., Dietmeier, W., Schlitt, H. J., Geissler, E. K., and Stoeltzing, O. (2010) Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. BMC Cancer 10, 668
20. Jan, Y.-H., Tsai, H.-Y., Yang, C.-J., Huang, M.-S., Yang, Y.-F., Lai, T.-C., Lee, C.-H., Jeng, Y.-M., Huang, C.-Y., Su, J.-L., Chuang, Y.-J., and Hsiao, M. (2012) Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor 3. Cancer Res. 72, 5119-5129
21. Yan, C., Wang, H., and Boyd, D. D. (2002) ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent transactivation of the collagenase promoter. J. Biol. Chem. 277, 10804-10812 (Pubitemid 34952834)
22. Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F. H., Goehler, H., Stroedicke, M., Zenkner, M., Schoenherr, A., Koeppen, S., Timm, J., Mintzlaff, S., Abraham, C., Bock, N., Kietzmann, S., Goedde, A., Toksöz, E., Droege, A., Krobitsch, S., Korn, B., Birchmeier, W., Lehrach, H., and Wanker, E. E. (2005) A human protein-protein interaction network. A resource for annotating the proteome. Cell 122, 957-968 (Pubitemid 41345212)
23. Yan, C., Lu, D., Hai, T., and Boyd, D. D. (2005) Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J. 24, 2425-2435 (Pubitemid 41032593)
24. Mo, P., Wang, H., Lu, H., Boyd, D. D., and Yan, C. (2010) MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J. Biol. Chem. 285, 26908-26915
25. Wang, H., Mo, P., Ren, S., and Yan, C. (2010) Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6. J. Biol. Chem. 285, 13201-13210
26. Wang, H., Jiang, M., Cui, H., Chen, M., Buttyan, R., Hayward, S. W., Hai, T., Wang, Z., and Yan, C. (2012) The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor. Mol. Cell. Biol. 32, 3190-3202
27. Brummelkamp, T. R., Bernards, R., and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (Pubitemid 34408678)
28. Yan, C., Wang, H., Toh, Y., and Boyd, D. D. (2003) Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. J. Biol. Chem. 278, 2309-2316 (Pubitemid 36801301)
29. Nair, R. R., Avila, H., Ma, X., Wang, Z., Lennartz, M., Darnay, B. G., Boyd, D. D., and Yan, C. (2008) A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression. Mol. Pharmacol. 73, 919-929 (Pubitemid 351397896)
30. Yan, C., and Boyd, D. D. (2006) Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol. Cell. Biol. 26, 6357-6371 (Pubitemid 44277877)
31. Scian, M. J., Stagliano, K. E., Anderson, M. A., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., and Deb, S. (2005) Tumor-derived p53 mutants induce NF-κB2 gene expression. Mol. Cell. Biol. 25, 10097-10110 (Pubitemid 41572755)
32. Bossi, G., Lapi, E., Strano, S., Rinaldo, C., Blandino, G., and Sacchi, A. (2006) Mutant p53 gain of function. Reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene 25, 304-309 (Pubitemid 43083692)
33. Yemelyanova, A., Vang, R., Kshirsagar, M., Lu, D., Marks, M. A., Shih, I. M., and Kurman, R. J. (2011) Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma. An immunohistochemical and nucleotide sequencing analysis. Mod. Pathol. 24, 1248-1253
34. Noll, J. E., Jeffery, J., Al-Ejeh, F, Kumar, R., Khanna, K. K., Callen, D. F., and Neilsen, P. M. (2012) Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11. Oncogene 31, 2836-2848
35. Valenti, F., Fausti, F., Biagioni, F., Shay, T., Fontemaggi, G., Domany, E., Yaffe, M. B., Strano, S., Blandino, G., and Di Agostino, S. (2011) Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop. Cell Cycle 10, 4330-4340
36. Liu, K., Ling, S., and Lin, W.-C. (2011) TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73. Mol. Cell. Biol. 31, 4464-4481
37. Lukashchuk, N., and Vousden, K. H. (2007) Ubiquitination and degradation of mutant p53. Mol. Cell Biol. 27, 8284-8295 (Pubitemid 350234240)
38. Terzian, T., Suh, Y.-A., Iwakuma, T., Post, S. M., Neumann, M., Lang, G. A., Van Pelt, C. S., and Lozano, G. (2008) The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev. 22, 1337-1344 (Pubitemid 351717524)
39. Oh, Y. K., Lee, H. J., Jeong, M.-H., Rhee, M., Mo, J.-W., Song, E. H., Lim, J.-Y., Choi, K.-H., Jo, I., Park, S. I., Gao, B., Kwon, Y., and Kim, W.-H. (2008) Role of activating transcription factor 3 on TAp73 stability and apoptosis in Paclitaxel-treated cervical cancer cells. Mol. Cancer Res. 6, 1232-1249
40. Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Siegfried, Z., Sigfried, Z., Shiff, I., Kogan, I., Shay, M., Kalo, E., Blandino, G., Simon, I., Oren, M., and Rotter, V. (2010) Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell 17, 273-285
41. Do, P. M., Varanasi, L., Fan, S., Li, C., Kubacka, I., Newman, V., Chauhan, K., Daniels, S. R., Boccetta, M., Garrett, M. R., Li, R., and Martinez, L. A. (2012) Mutant p53 cooperates with ETS2 to promote etoposide resistance. Genes Dev. 26, 830-845
42. Ishiguro, T., Nakajima, M., Naito, M., Muto, T., and Tsuruo, T. (1996) Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res. 56, 875-879 (Pubitemid 26055480)
43. Stearns, M. E., Kim, G., Garcia, F., and Wang, M. (2004) Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 cells. Mol. Cancer Res. 2, 403-416 (Pubitemid 39031074)
44. Zigler, M., Villares, G. J., Dobroff, A. S., Wang, H., Huang, L., Braeuer, R. R., Kamiya, T., Melnikova, V. O., Song, R., Friedman, R., Alani, R. M., and Bar-Eli, M. (2011) Expression of Id-1 is regulated by MCAM/MUC18. A missing link in melanoma progression. Cancer Res. 71, 3494-3504
45. Bottone, F. G., Jr., Moon, Y., Kim, J. S., Alston-Mills, B., Ishibashi, M., and Eling, T. E. (2005) The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Mol. Cancer Ther. 4, 693-703 (Pubitemid 40767113)
46. Maeda, T., Hobbs, R. M., Merghoub, T., Guernah, I., Zelent, A., Cordon-Cardo, C., Teruya-Feldstein, J., and Pandolfi, P. P. (2005) Role of the protooncogene Pokemon in cellular transformation and ARF repression. Nature 433, 278-285
47. Wang, G., Lunardi, A., Zhang, J., Chen, Z., Ala, U., Webster, K. A., Tay, Y., Gonzalez-Billalabeitia, E., Egia, A., Shaffer, D. R., Carver, B., Liu, X.-S., Taulli, R., Kuo, W. P., Nardella, C., Signoretti, S., Cordon-Cardo, C., Gerald, W. L., and Pandolfi, P. P. (2013) Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat. Genet. 45, 739-746